期刊文献+

TSP-1和VEGF在胃癌微血管生成中的调控作用及其临床意义 被引量:2

Regulating Role and Clinical Meaning of TSP-1 and VEGF in Mierovascularization of Gastric Cancer
原文传递
导出
摘要 目的:探讨TSP-1和VEGF在胃癌微血管生成中的调控作用及临床意义.方法:采用免疫组织化学SP法检测85例胃癌组织(实验组)以及癌缘外≥5 cm远隔胃黏膜组织(对照组)中TSP-1、VEGF和CD31表达水平,研究TSP-1和VEGF的表达与微血管密度(MVD)的相关关系.结果:(1)实验组TSP-1、VEGF阳性率分别为40%(34/85)、81.2%(69/85),较对照组明显增高(p<0.01);(2)TSP-1的表达与MVD呈负相关(p<0.01),VEGF的表达与MVD的表达呈正相关(p<0.01).结论:胃癌中TSP-1和VEGF的表达与血管新生关系密切,是调控血管生成的重要因素,两者表达平衡决定胃癌新生血管生成. Objective:To discuss the regulating role and clinical meaning of TSP- 1 and VEGF in microvascularization of gastric cancer. Methods: A total of 85 cases of gastric carcinoma and its normal tissue were studied with SP immunohistochemical technique to evaluate the relation of the expressions of TSP - 1, VEGF with micmvessel density. Results: ( 1 ) 34 cases for TSP - 1 (40%) and 69 cases for VEGF (81.2%) protein were positive respectively . The expression rate of TSP - 1 and VEGF were higher in gastric carcinoma than in its normal gastric tissue(P 〈0.05). (2). Gastric carcinoma tissue with a high expression of TSP- 1 showed a low value of MVD while a high expression of VEGF showed a high expression of MVD. Conclusions: ( 1 ) It is suggested that TSP - 1 and VEGF play an important role in neovaseularization and invasive growth in gastric carcinoma. The balance down - expression of TSP - 1 and VEGF is one of the key factors for neovaseularization in gastrie cancer.
出处 《解剖与临床》 2010年第4期246-249,共4页 Anatomy and Clinics
关键词 胃癌 TSP-1 VEGF 微血管密度 免疫组织化学技术 TSP-1 VEGF Mierovessel density Gastric carcinoma Immunohistoehemieal technique
  • 相关文献

参考文献3

二级参考文献34

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:337
  • 2邢承忠,郭晓临,刘瑾,徐惠绵,袁媛.胃癌组织和胃周淋巴结COX-2mRNA的表达及其意义[J].中国肿瘤临床,2006,33(2):74-76. 被引量:6
  • 3Li Zhang,Zhong-Sheng Zhao,Guo-Qing Ru,Jie Ma.Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer[J].World Journal of Gastroenterology,2006,12(25):3970-3976. 被引量:13
  • 4takahashi R, Tanaka S, Hiyama T, et al. Hypoxia-inducible factor-lalpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach[J]. Oncol Rep, 2003, 10(4): 797-802.
  • 5Clczardin P, Frappart L, Clerget M, ct al. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal,hyperplastic, and neoplastic human breast [1]. Cancer Res, 1993,53(6): 1421-1430.
  • 6Tanaka K, Sonoo H, Kurebayashi J, et al. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma[J]. Clin Cancer Res, 2002, 8(5): 1125-1131.
  • 7Benin N, Clezardin P, Kubiak R, et al. Thrombospondin-1 and-2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia [J]. Cancer Res, 1997,57(3): 396-399.
  • 8Kwak C, Jin C, Lee C, et al. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia [J]. BJU Int, 2002, 89(3): 303-309.
  • 9Kasper HU, Ebert M, Malfertheiner P, et al. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density[l]. Virchows Arch, 2001, 438(2): 116-120.
  • 10Maeda K, Nishiguchi Y, Yashiro M, et al. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma[J]. IntJ Mol Med, 2000, 5(4): 373-378.

共引文献4

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部